1. Home
  2. WLDS vs CMMB Comparison

WLDS vs CMMB Comparison

Compare WLDS & CMMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wearable Devices Ltd.

WLDS

Wearable Devices Ltd.

HOLD

Current Price

$1.64

Market Cap

10.9M

ML Signal

HOLD

Logo Chemomab Therapeutics Ltd.

CMMB

Chemomab Therapeutics Ltd.

HOLD

Current Price

$1.67

Market Cap

11.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WLDS
CMMB
Founded
2014
2004
Country
Israel
Israel
Employees
N/A
N/A
Industry
Computer Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.9M
11.2M
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
WLDS
CMMB
Price
$1.64
$1.67
Analyst Decision
Buy
Analyst Count
0
1
Target Price
N/A
$25.00
AVG Volume (30 Days)
58.3K
38.7K
Earning Date
03-12-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
101.67
EPS
N/A
0.04
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$42.00
Revenue Growth
N/A
N/A
52 Week Low
$0.64
$0.87
52 Week High
$11.40
$3.86

Technical Indicators

Market Signals
Indicator
WLDS
CMMB
Relative Strength Index (RSI) 66.53 49.25
Support Level $1.05 $1.44
Resistance Level $1.93 $1.86
Average True Range (ATR) 0.12 0.13
MACD 0.02 0.01
Stochastic Oscillator 96.30 54.76

Price Performance

Historical Comparison
WLDS
CMMB

About WLDS Wearable Devices Ltd.

Wearable Devices Ltd develops and sells human-machine interface solutions for the smart wearables industry. These digital devices include consumer electronics, smart watches, smartphones, AR glasses, VR headsets, televisions, PCs, laptop computers, drones, robots, etc. The company has completed the transition phase from research and development to commercialization of technology into B2B and B2C products. Its products include Mudra Inspire, a band for the Apple Watch that allows touchless operation and control of Apple ecosystem devices such as iPhone, Mac computer, Apple TV, and iPad, inter alia.

About CMMB Chemomab Therapeutics Ltd.

Chemomab Therapeutics Ltd is a clinical-stage biotechnology company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin, and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life-threatening fibrotic and inflammatory diseases.

Share on Social Networks: